$4.64
-0.07-1.48%
Last update: Sep 20, 4:00 PM
15 minutes delayed
Comments
Loading...
Champions Oncology (CSBR) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestChampions Oncology (NASDAQ:CSBR) Stock Quotes, Forecast and News Summary
Champions Oncology Stock (NASDAQ: CSBR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Champions Oncology (CSBR) stock?
You can purchase shares of Champions Oncology (NASDAQ:CSBR) through any online brokerage.
Who are Champions Oncology (CSBR) competitors?
Other companies in Champions Oncology’s space includes: Harvard Bioscience (NASDAQ:HBIO), CryoPort (NASDAQ:CYRX), Codexis (NASDAQ:CDXS), Personalis (NASDAQ:PSNL) and Quantum-Si (NASDAQ:QSI).
What is the forecast, or price target, for Champions Oncology (CSBR) stock?
Champions Oncology has a consensus price target of $6.75.
What is the current price for Champions Oncology (CSBR)?
The stock price for Champions Oncology (NASDAQ: CSBR) is $4.73 last updated September 25, 2024 at 12:58 PM EDT.
Does Champions Oncology (CSBR) pay a dividend?
There are no upcoming dividends for Champions Oncology.
When is Champions Oncology (NASDAQ:CSBR) reporting earnings?
Champions Oncology’s Q2 earnings are confirmed for Tuesday, December 10, 2024.
Is Champions Oncology (CSBR) going to split?
There is no upcoming split for Champions Oncology.
What sector and industry does Champions Oncology (CSBR) operate in?
Champions Oncology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.